Results 271 to 280 of about 14,877 (300)

Similar anti-inflammatory effects of intracoronary and intravenous Abciximab during primary percutaneous coronary intervention: a randomized study

Journal of Cardiovascular Medicine, 2015
G. Secco, M. Sansa, A. Rognoni, R. Parisi, R. Fattori, L. Rossi, M. Lazzero, R. Rolla, G. Bellomo, A. Bongo, P. Agostoni, C. Di Mario, A. Lupi   +12 more
semanticscholar   +1 more source

Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials.

EuroIntervention, 2014
R. Piccolo, I. Eitel, A. Iversen, Youlan L. Gu, A. Domínguez-Rodríguez, B. D. de Smet, K. Mahmoud, P. Abreu-González, H. Thiele, F. Piscione   +9 more
semanticscholar   +1 more source

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

Journal of the American Medical Association (JAMA), 2006
A. Kastrati, J. Mehilli, F. Neumann, F. Dotzer, J. T. ten Berg, H. Bollwein, Isolde Graf, Maryam Ibrahim, J. Pache, M. Seyfarth, H. Schühlen, J. Dirschinger, P. Berger, A. Schömig   +13 more
semanticscholar   +1 more source

AIDA STEMI: no benefit for intracoronary abciximab

The Lancet, 2012
Sanjit S. Jolly, Olivier F. Bertrand
openaire   +3 more sources

Treatment of radial artery occlusions using balloon angioplasty and localized intra-arterial abciximab.

Journal of interventional cardiology, 2014
Z. Jaradat, Babar B. Basir, G. Revtyak
semanticscholar   +1 more source

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading

Circulation, 2009
Julinda Mehilli, Adnan Kastrati, Stefanie Schulz   +2 more
exaly  

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial

Stroke, 2008
Mark B Effron, Werner Hacke
exaly  

Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

Journal of the American Medical Association (JAMA), 2005
G. De Luca, H. Suryapranata, G. Stone, D. Antoniucci, J. Tcheng, F. Neumann, F. Van de Werf, E. Antman, E. Topol   +8 more
semanticscholar   +1 more source

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

Lancet, The, 2002
Adnan Kastrati, Melchior Seyfarth, Markus Schwaiger   +2 more
exaly  

Targeting integrin pathways: mechanisms and advances in therapy

Signal Transduction and Targeted Therapy, 2023
exaly